---
figid: PMC3886746__jah3-2-e000536-g1
figtitle: cGMP signaling pathways
organisms:
- Mus musculus
- Rattus norvegicus
- Oryctolagus cuniculus
- Canis lupus familiaris
- Homo sapiens
organisms_ner:
- Homo sapiens
- Rattus norvegicus
- Mus musculus
- Drosophila melanogaster
pmcid: PMC3886746
filename: jah3-2-e000536-g1.jpg
figlink: /pmc/articles/PMC3886746/figure/fig01/
number: F1
caption: 'cGMP signaling pathways. cGMP is the second messenger of 2 distinct signaling
  pathways: (1) NO is produced by endothelial cells and binds to sGC in the target
  cell; and (2) ANP and BNP, derived primarily from cardiomyocytes, stimulate GC‐A,
  whereas CNP, secreted by endothelial cells, stimulates GC‐B. cGMP signaling may
  be augmented by (1) the use of NO mimetics such as nitrovasodilators; (2) sGC activators
  or stimulators; (3) increasing levels of natriuretic peptides; (4) by inhibiting
  natriuretic peptide degrading enzymes; and (5) inhibiting the activity of cGMP‐hydrolyzing
  PDEs. ANP indicates atrial natriuretic peptide; BNP, B‐type natriuretic peptide;
  cGMP, cyclic guanosine monophosphate; CNP, C‐type natriuretic peptide; DPP4, dipeptidyl
  peptidase IV; GC, guanylate cyclase; GMP, guanosine monophosphate; NEP, neutral
  endopeptidase; NO, nitric oxide; PDE, phosphodiesterase; PKG, protein kinase G;
  RA, natriuretic peptide receptor A; sGC, soluble guanylate cyclase. Adapted with
  permission from Boerrigter et al.'
papertitle: The cGMP Signaling Pathway as a Therapeutic Target in Heart Failure With
  Preserved Ejection Fraction.
reftext: Stephen J. Greene, et al. J Am Heart Assoc. 2013 Dec;2(6):e000536.
year: '2013'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9437683
figid_alias: PMC3886746__F1
figtype: Figure
redirect_from: /figures/PMC3886746__F1
ndex: 8ee76e67-dee5-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3886746__jah3-2-e000536-g1.html
  '@type': Dataset
  description: 'cGMP signaling pathways. cGMP is the second messenger of 2 distinct
    signaling pathways: (1) NO is produced by endothelial cells and binds to sGC in
    the target cell; and (2) ANP and BNP, derived primarily from cardiomyocytes, stimulate
    GC‐A, whereas CNP, secreted by endothelial cells, stimulates GC‐B. cGMP signaling
    may be augmented by (1) the use of NO mimetics such as nitrovasodilators; (2)
    sGC activators or stimulators; (3) increasing levels of natriuretic peptides;
    (4) by inhibiting natriuretic peptide degrading enzymes; and (5) inhibiting the
    activity of cGMP‐hydrolyzing PDEs. ANP indicates atrial natriuretic peptide; BNP,
    B‐type natriuretic peptide; cGMP, cyclic guanosine monophosphate; CNP, C‐type
    natriuretic peptide; DPP4, dipeptidyl peptidase IV; GC, guanylate cyclase; GMP,
    guanosine monophosphate; NEP, neutral endopeptidase; NO, nitric oxide; PDE, phosphodiesterase;
    PKG, protein kinase G; RA, natriuretic peptide receptor A; sGC, soluble guanylate
    cyclase. Adapted with permission from Boerrigter et al.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CNP
  - NPPC
  - DDR1
  - MME
  - DPP4
  - FAP
  - GCA
  - NPR2
  - SGCB
  - GUCY1A2
  - GUCY1A1
  - GUCY1B1
  - GUCY1B2
  - NT5C2
  - ALDH7A1
  - PDE2A
  - PDE9A
  - PDE10A
  - PDE11A
  - PDE1A
  - PDE1B
  - PDE1C
  - PDE3A
  - PDE3B
  - PDE4A
  - PDE4B
  - PDE4C
  - PDE4D
  - PDE6A
  - PDE6B
  - PDE6C
  - PDE7A
  - PDE7B
  - PDE8A
  - PDE8B
  - PRKG1
  - Cnp
  - Mme
  - Dpp4
  - Gca
  - Npr1
  - Npr2
  - Gucy1b1
  - Gucy1b2
  - Gucy1a1
  - Nppc
  - Ddr1
  - Tns2
  - Guca1a
  - Srgn
  - Nt5c2
  - Twist1
  - Np
  - Pkg21D
  - Nep1
  - ra
  - rc
  - tRNA:Ala-TGC-1-1
  - tRNA:Ala-TGC-2-1
  - Gycalpha99B
  - fliF
  - dnc
  - for
---
